Evolution Wealth Advisors LLC Sells 105 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Evolution Wealth Advisors LLC reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 0.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,058 shares of the financial services provider’s stock after selling 105 shares during the quarter. Evolution Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,861,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of IBB. Vontobel Holding Ltd. increased its holdings in iShares Biotechnology ETF by 9.5% in the 1st quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock valued at $659,000 after buying an additional 440 shares during the period. Blair William & Co. IL increased its holdings in iShares Biotechnology ETF by 9.7% in the 1st quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock valued at $2,439,000 after buying an additional 1,659 shares during the period. NewEdge Advisors LLC increased its holdings in iShares Biotechnology ETF by 11.7% in the 1st quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock valued at $1,796,000 after buying an additional 1,445 shares during the period. DCF Advisers LLC acquired a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $912,000. Finally, Laurel Wealth Advisors Inc. boosted its stake in shares of iShares Biotechnology ETF by 22.6% in the 1st quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock valued at $393,000 after purchasing an additional 557 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB traded up $0.08 during mid-day trading on Friday, reaching $124.72. The company had a trading volume of 1,996,759 shares, compared to its average volume of 1,810,208. The company’s 50 day simple moving average is $135.09 and its 200 day simple moving average is $129.54. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16. The company has a market capitalization of $6.93 billion, a price-to-earnings ratio of 16.28 and a beta of 0.84.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.40%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.